{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:48:01Z","timestamp":1783464481531,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00284-022-02794-9","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T10:04:59Z","timestamp":1647597899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Repositioning of Disulfiram in Association with Vancomycin Against Enterococcus spp. MDR and XDR"],"prefix":"10.1007","volume":"79","author":[{"given":"Marissa B.","family":"Serafin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit\u00f3ria S.","family":"Foletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taci\u00e9li F.","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelita","family":"Bottega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altevir Rossato","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00edsa Nunes","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"de Lima Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto Dias","family":"da Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Rafael","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Maria Fontanari","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Junior","family":"Finatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredo","family":"H\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosmari","family":"H\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"2794_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101092","volume":"23","author":"M Alipour","year":"2021","unstructured":"Alipour M, Rajabi M, Khalili R, Torkamanzadeh P (2021) Prevalence of antibiotic resistance genes among Enterococcus strains isolated from the clinical specimens. Gene Reports 23:101092. https:\/\/doi.org\/10.1016\/j.genrep.2021.101092","journal-title":"Gene Reports"},{"key":"2794_CR2","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/jac\/dkw312","volume":"71","author":"L Garcia-Migura","year":"2016","unstructured":"Garcia-Migura L, Willems RJ, Baquero F, Coque TM (2016) Multilevel populationgenetic analysis of vanA and vanB Enterococcus faecium causing nosocomialoutbreaks in 27 countries (1986\u20132012). J Antimicrob Chemother 71:3351\u20133366.\u00a0https:\/\/doi.org\/10.1093\/jac\/dkw312","journal-title":"J Antimicrob Chemother"},{"key":"2794_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1017\/ice.2016.254","volume":"38","author":"HY Chiang","year":"2017","unstructured":"Chiang HY, Perencevich EN, Nair R et al (2017) Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: systematic literature review andmeta-analysis. Infect Control Hosp Epidemiol 38:203\u2013215.\u00a0https:\/\/doi.org\/10.1017\/ice.2016.254","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2794_CR4","unstructured":"WHO\/CDC\/ICBDSR. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva: World Health Organization; 2017.Available at: http:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/ [accessed 10.06.2021]."},{"key":"2794_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bjid.2018.05.007","volume":"22","author":"MB Serafin","year":"2018","unstructured":"Serafin MB, H\u00f6rner R (2018) Drug repositioning, a new alternative in infectious diseases. Braz J Infec Dis 22:252\u2013256.\u00a0https:\/\/doi.org\/10.1016\/j.bjid.2018.05.007","journal-title":"Braz J Infec Dis"},{"issue":"3","key":"2794_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106380","volume":"58","author":"VS Foletto","year":"2021","unstructured":"Foletto VS, da Rosa TF, Serafin MB et al (2021) Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review. Int J Antimicrob Agents 58(3):106380. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106380","journal-title":"Int J Antimicrob Agents"},{"key":"2794_CR7","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1039\/C5MB00306G","volume":"11","author":"Y Yeu","year":"2015","unstructured":"Yeu Y, Yoon Y, Park S (2015) Protein localization vector propagation: a method for improving the accuracy of drug repositioning. Mol Bio Syst 11:2096\u20132102.\u00a0https:\/\/doi.org\/10.1039\/C5MB00306G","journal-title":"Mol Bio Syst"},{"key":"2794_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","volume":"19","author":"G Jin","year":"2014","unstructured":"Jin G, Wong S (2014) Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today 19:637\u2013644. https:\/\/doi.org\/10.1016\/j.drudis.2013.11.005","journal-title":"Drug Discov Today"},{"key":"2794_CR9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.18632\/oncotarget.604","volume":"3","author":"J Triscott","year":"2012","unstructured":"Triscott J, Lee CK et al (2012) Disulfiram, a drug widely used to control alcoholism, suppressesself-renewal of glioblastoma and overrides resistance to temozolomide. Oncotarget 3:1112\u20131123.\u00a0https:\/\/doi.org\/10.18632\/oncotarget.604","journal-title":"Oncotarget"},{"key":"2794_CR10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1128\/AAC.00898-17","volume":"61","author":"TE Long","year":"2017","unstructured":"Long TE (2017) Repurposing thiram and disulfiram as antibacterial agents for multidrug-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 61:898\u2013917. https:\/\/doi.org\/10.1128\/AAC.00898-17","journal-title":"Antimicrob Agents Chemother"},{"key":"2794_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbrc.2006.01.003","volume":"341","author":"R Velasco-Garc\u00eda","year":"2006","unstructured":"Velasco-Garc\u00eda R, Zald\u00edvar-Machorro VJ, M\u00fajica-Jim\u00e9nez C et al (2006) Disulfiram irreversibly aggregates betaine aldehyde dehydrogenase - A potential target for antimicrobial agents against Pseudomonas aeruginosa. Biochem Biophys Res Commun 341:408\u2013415.\u00a0https:\/\/doi.org\/10.1016\/j.bbrc.2006.01.003","journal-title":"Biochem Biophys Res Commun"},{"key":"2794_CR12","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1128\/AAC.06445-11","volume":"56","author":"Y Horita","year":"2012","unstructured":"Horita Y, Takii T, Yagi T et al (2012) Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 56:4140\u20134145. https:\/\/doi.org\/10.1128\/AAC.06445-11","journal-title":"Antimicrob Agents Chemother"},{"key":"2794_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nchembio.1911","volume":"11","author":"PR Gonz\u00e1les","year":"2015","unstructured":"Gonz\u00e1les PR, Pesesky MW, Bouley R et al (2015) Synergistic, collaterally sensitive \u03b2-lactam combinations suppress resistance in MRSA. Nat Chem Biol 11:855\u2013861.\u00a0https:\/\/doi.org\/10.1038\/nchembio.1911","journal-title":"Nat Chem Biol"},{"key":"2794_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00044-020-02507-6","volume":"29","author":"VS Foletto","year":"2020","unstructured":"Foletto VS, Serafin MB, Bottega A et al (2020) Repositioning of fluoxetine and paroxetine: study of potential antibacterial activity and its combination with ciprofloxacin. Med Chem Res 29:556\u2013563. https:\/\/doi.org\/10.1007\/s00044-020-02507-6","journal-title":"Med Chem Res"},{"issue":"8","key":"2794_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1139\/cjm-2020-0546","volume":"67","author":"TF Da Rosa","year":"2021","unstructured":"Da Rosa TF, Machado CS, Serafin MB et al (2021) Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole\/trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA. Can J Microbiol 67(8):599\u2013612. https:\/\/doi.org\/10.1139\/cjm-2020-0546","journal-title":"Can J Microbiol"},{"key":"2794_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ijantimicag.2019.03.024","volume":"53","author":"R Thakare","year":"2019","unstructured":"Thakare R, Shukla M, Kaul G et al (2019) Repurposing disulfiram for treatment of Staphylococcus aureus infections. Int J Antimicrob Agents 53:709\u2013715.\u00a0https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.024","journal-title":"Int J Antimicrob Agents"},{"key":"2794_CR17","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing,\u00a0Clinical and Laboratory Standards Institute,\u00a0Wayne, PA\u00a0(2019), CLSI supplement M100."},{"key":"2794_CR18","doi-asserted-by":"publisher","first-page":"268e81","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2011","unstructured":"Magiorakos AP, Srinivasan A, Carey RB et al (2011) Multidrug-resistant, extensively drug resistantand pandrug-resistant bacteria: an international expert pro-posal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268e81.\u00a0https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"2794_CR19","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M07\u2013A9. Wayne, USA (2012), CLSI."},{"key":"2794_CR20","first-page":"365","volume-title":"Antibiotics in Laboratory Medicine","author":"V Lorian","year":"2005","unstructured":"Lorian V (2005) Antibiotics in Laboratory Medicine, 5th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 365\u2013441","edition":"5"},{"key":"2794_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-0711-11-18","volume":"11","author":"K Konat\u00e9","year":"2012","unstructured":"Konat\u00e9 K, Mavoungou JF, Lepengu\u00e9 AN, Aworet-Samveny RR, Hilou A, Souza A et al (2012) Antibacterial activity against \u03b2-lactamase producing Methicillin and Ampicillin-resistants Staphylococcus aureus: fractional Inhibitory Concentration Index (FICI) determination. Ann Clin Microbiol Antimicrob 11:18. https:\/\/doi.org\/10.1186\/1476-0711-11-18","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2794_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/bjc.1987.190","volume":"56","author":"PR Twentyman","year":"1987","unstructured":"Twentyman PR, Luscombe M (1987) A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56:279\u2013285.\u00a0https:\/\/doi.org\/10.1038\/bjc.1987.190","journal-title":"Br J Cancer"},{"key":"2794_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13404-013-0091-z","volume":"46","author":"CY Yeo","year":"2013","unstructured":"Yeo CY, Sim JH, Khoo CH et al (2013) Pathogenic Gram positive bacteria are highly sensitive to triphenylphosphane gold (Oalkylthiocarbamates), Ph3PAu[SC(OR)=N(p-tolyl)] (R=Me, Et and iPr). Gold Bull 46:145\u2013152.\u00a0https:\/\/doi.org\/10.1007\/s13404-013-0091-z","journal-title":"Gold Bull"},{"issue":"187","key":"2794_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.00187","volume":"6","author":"VV Loi","year":"2015","unstructured":"Loi VV, Rossius M, Antelmann H (2015) Redox regulation by reversible protein S-thiolation in bacteria. Front Microbiol 6(187):1\u201322. https:\/\/doi.org\/10.3389\/fmicb.2015.00187","journal-title":"Front Microbiol"},{"key":"2794_CR25","doi-asserted-by":"publisher","DOI":"10.5772\/29628","author":"T Takii","year":"2012","unstructured":"Takii T, Horita Y, Kuroishi R, Chibal T (2012) The potential therapeutic usage of dithiocarbamate sugar derivatives for multi-drug resistant tuberculosis. Understanding Tuberculosis. https:\/\/doi.org\/10.5772\/29628","journal-title":"Understanding Tuberculosis"},{"issue":"4","key":"2794_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/bjc.2013.18","volume":"2013","author":"B Cvek","year":"2013","unstructured":"Cvek B (2013) Comment on cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br J Cancer 2013(4):993. https:\/\/doi.org\/10.1038\/bjc.2013.18","journal-title":"Br J Cancer"},{"key":"2794_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","volume":"18","author":"MD Zilberberg","year":"2014","unstructured":"Zilberberg MD, Shorr AF, Micek ST et al (2014) Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care 18:596.\u00a0https:\/\/doi.org\/10.1186\/s13054-014-0596-8","journal-title":"Crit Care"},{"key":"2794_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ja.2010.62","volume":"63","author":"S Donadio","year":"2010","unstructured":"Donadio S, Maffioli S, Monciardini P et al (2010) Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot 63:423\u2013430.\u00a0https:\/\/doi.org\/10.1038\/ja.2010.62","journal-title":"J Antibiot"},{"issue":"12","key":"2794_CR29","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.1016\/j.ajic.2017.08.044","volume":"45","author":"P Lloyd-Smith","year":"2017","unstructured":"Lloyd-Smith P (2017) Controlling for endogeneity in attributable costs of vancomycin-resistant enterococci from a Canadian hospital. Am J Infect Control 45(12):E161\u2013E164.\u00a0https:\/\/doi.org\/10.1016\/j.ajic.2017.08.044","journal-title":"Am J Infect Control"},{"key":"2794_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/jcpt.13149","volume":"45","author":"TF Da Rosa","year":"2020","unstructured":"Da Rosa TF, Coelho SS, Foletto VS et al (2020) Alternatives for the treatment of infections caused by ESKAPE pathogens. J Clin Pharm Ther 45:863\u2013887.\u00a0https:\/\/doi.org\/10.1111\/jcpt.13149","journal-title":"J Clin Pharm Ther"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-022-02794-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T19:10:31Z","timestamp":1650136231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-022-02794-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2794"],"URL":"https:\/\/doi.org\/10.1007\/s00284-022-02794-9","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Author elects to not share data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"None to declare.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency Declarations"}},{"value":"The use of bacterial isolates for clinical research was approved by the Ethics and Research Committee (CEP) of the Federal University of Santa Maria (UFSM), registered under number 38850614.4.0000.5346, opinion number 928,497. Registration in the National System for the Management of Genetic Heritage and Associated Traditional Knowledge (SisGen) was registered under number AE78E18 \u2013UFSM.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"137"}}